GSK PLC (GSK)
39.27
-0.33
(-0.83%)
USD |
NYSE |
Apr 18, 16:00
39.28
+0.01
(+0.03%)
Pre-Market: 20:00
GSK Cash from Investing (TTM): -1.985B for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -1.985B |
September 30, 2023 | -3.533B |
June 30, 2023 | -7.378B |
March 31, 2023 | -6.538B |
December 31, 2022 | -10.86B |
September 30, 2022 | -10.18B |
June 30, 2022 | -7.321B |
March 31, 2022 | -7.199B |
December 31, 2021 | -2.445B |
September 30, 2021 | -2.039B |
June 30, 2021 | -990.95M |
March 31, 2021 | 2.782B |
December 31, 2020 | 2.774B |
September 30, 2020 | 2.165B |
June 30, 2020 | 2.406B |
March 31, 2020 | -1.762B |
December 31, 2019 | -6.836B |
September 30, 2019 | -6.728B |
June 30, 2019 | -7.013B |
March 31, 2019 | -6.705B |
December 31, 2018 | -2.072B |
September 30, 2018 | -1.898B |
June 30, 2018 | -1.900B |
March 31, 2018 | -2.133B |
December 31, 2017 | -1.863B |
Date | Value |
---|---|
September 30, 2017 | -1.731B |
June 30, 2017 | -1.222B |
March 31, 2017 | -1.011B |
December 31, 2016 | -1.719B |
September 30, 2016 | -2.226B |
June 30, 2016 | -2.259B |
March 31, 2016 | -2.476B |
December 31, 2015 | 9.226B |
September 30, 2015 | 9.403B |
June 30, 2015 | 9.197B |
March 31, 2015 | 9.522B |
December 31, 2014 | -1.777B |
September 30, 2014 | 1.675B |
June 30, 2014 | 1.202B |
March 31, 2014 | 730.11M |
December 31, 2013 | 819.84M |
September 30, 2013 | -2.432B |
June 30, 2013 | -5.407B |
March 31, 2013 | -4.858B |
December 31, 2012 | -4.169B |
September 30, 2012 | -4.506B |
June 30, 2012 | -1.085B |
March 31, 2012 | -1.291B |
December 31, 2011 | -179.59M |
September 30, 2011 | -277.50M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-10.86B
Minimum
Dec 2022
2.782B
Maximum
Mar 2021
-3.826B
Average
-3.533B
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
AstraZeneca PLC | -4.064B |
Haleon PLC | -- |
Novo Nordisk A/S | -6.373B |
Pfizer Inc | -32.28B |
Sanofi SA | -- |